Dare Bioscience, Inc. Payments to Acquire Businesses, Gross
Dare Bioscience, Inc. (DARE) reported Payments to Acquire Businesses, Gross of $0 for the 9-month period ending 2019-09-30, per its 10-Q filed 2019-11-12.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireBusinessesGross · last filed 2019-11-12
- Dare Bioscience, Inc. payments to acquire businesses, gross for the quarter ending 2019-09-30 was $0.00, a 100.00% decline year-over-year.
- Dare Bioscience, Inc. payments to acquire businesses, gross for the quarter ending 2018-09-30 was $55.00K.
| Period end | Payments to Acquire Businesses, Gross 3 month | Payments to Acquire Businesses, Gross 6 month | Payments to Acquire Businesses, Gross 9 month |
|---|---|---|---|
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $0.00 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $0.00 10-Q · filed 2019-08-14 | ||
| 2018-09-30 | $55.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $507.00K 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $452.00K 10-Q · filed 2019-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |